VLX600
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VLX600, covering 2018-05-11 to 2018-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors [Phase 1]